These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 30987853

  • 21. Spatial behavior of hepatitis A, MMR, and varicella vaccination coverage in the state of Minas Gerais, 2020.
    Oliveira GCCF, Arroyo LH, Vimieiro AM, Gusmão JD, Oliveira VC, Guimarães EAA.
    Rev Bras Epidemiol; 2023; 26():e230030. PubMed ID: 37377251
    [Abstract] [Full Text] [Related]

  • 22. Measles, Mumps, and Rubella Serostatus and Response to MMR Vaccination Among HIV-Infected Adults.
    Singh HK, Chiu YL, Wilkin T.
    AIDS Patient Care STDS; 2015 Sep; 29(9):461-4. PubMed ID: 26153909
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Safety and characterization of the immune response engendered by two combined measles, mumps and rubella vaccines.
    Schwarzer S, Reibel S, Lang AB, Struck MM, Finkel B, Gerike E, Tischer A, Gassner M, Glück R, Stück B, Cryz SJ.
    Vaccine; 1998 Sep; 16(2-3):298-304. PubMed ID: 9607046
    [Abstract] [Full Text] [Related]

  • 26. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).
    McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS, Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 2013 Jun 14; 62(RR-04):1-34. PubMed ID: 23760231
    [Abstract] [Full Text] [Related]

  • 27. Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months.
    Kontio M, Palmu AA, Syrjänen RK, Lahdenkari M, Ruokokoski E, Davidkin I, Vaarala O, Melin M.
    J Infect Dis; 2016 Jun 15; 213(12):2005-13. PubMed ID: 26908733
    [Abstract] [Full Text] [Related]

  • 28. Open randomized trial comparing the immunogenicity and safety of a new measles-mumps-rubella vaccine and a licensed vaccine in 12- to 24-month-old children.
    Feiterna-Sperling C, Brönnimann R, Tischer A, Stettler P, Durrer P, Gaedicke G.
    Pediatr Infect Dis J; 2005 Dec 15; 24(12):1083-8. PubMed ID: 16371870
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The web and public confidence in MMR vaccination in Italy.
    Aquino F, Donzelli G, De Franco E, Privitera G, Lopalco PL, Carducci A.
    Vaccine; 2017 Aug 16; 35(35 Pt B):4494-4498. PubMed ID: 28736200
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Opportunistic MMR vaccination for unimmunized children at the time of routine teenage booster vaccination in secondary schools: implications for policy.
    Paranthaman K, Bunce A.
    Epidemiol Infect; 2012 Sep 16; 140(9):1612-6. PubMed ID: 22117122
    [Abstract] [Full Text] [Related]

  • 33. The virtual elimination of rubella and mumps from the United States and the use of combined measles, mumps and rubella vaccines (MMR) to eliminate measles.
    Bart KJ, Orenstein WA, Hinman AR.
    Dev Biol Stand; 1986 Sep 16; 65():45-52. PubMed ID: 3104117
    [Abstract] [Full Text] [Related]

  • 34. Determinants of European parents' decision on the vaccination of their children against measles, mumps and rubella: A systematic review and meta-analysis.
    Tabacchi G, Costantino C, Napoli G, Marchese V, Cracchiolo M, Casuccio A, Vitale F, The Esculapio Working Group.
    Hum Vaccin Immunother; 2016 Jul 02; 12(7):1909-23. PubMed ID: 27163657
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Number of doses of Measles-Mumps-Rubella vaccine applied in Brazil before and during the COVID-19 pandemic.
    da Silva TMR, de Sá ACMGN, Vieira EWR, Prates EJS, Beinner MA, Matozinhos FP.
    BMC Infect Dis; 2021 Dec 09; 21(1):1237. PubMed ID: 34886804
    [Abstract] [Full Text] [Related]

  • 37. Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age.
    Ceyhan M, Kanra G, Erdem G, Kanra B.
    Vaccine; 2001 Aug 14; 19(31):4473-8. PubMed ID: 11483273
    [Abstract] [Full Text] [Related]

  • 38. Healthcare workers and measles-mumps-rubella (MMR) status: how worried should we be about further outbreaks?
    Basu S, Giri P, Adisesh A, McNAUGHT R.
    Epidemiol Infect; 2014 Aug 14; 142(8):1688-94. PubMed ID: 24229805
    [Abstract] [Full Text] [Related]

  • 39. The evolution of vaccines for early childhood: the MMRV.
    Ferrera G, Squeri R, Genovese C.
    Ann Ig; 2018 Aug 14; 30(4 Supple 1):33-37. PubMed ID: 30062378
    [Abstract] [Full Text] [Related]

  • 40. Measles, mumps, and rubella vaccine coverage in 2 year old children in East Lancashire--better than it looks.
    Clark A, Marshall R.
    Commun Dis Public Health; 1999 Jan 14; 2(1):50-3. PubMed ID: 10462897
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.